Refine your search
-
Authors
-
Item types
-
Topics
- *Alemtuzumab/tu [Therapeutic Use]
- *Glucocorticoids/pk [Pharmacokinetics]
- *Lactation
- *Multiple Sclerosis, Relapsing-Remitting/dt [Drug Therapy]
- *Prednisone/pk [Pharmacokinetics]
- Alemtuzumab/ae [Adverse Effects]
- Alemtuzumab/pk [Pharmacokinetics]
- Area Under Curve
- CD52 Antigen/im [Immunology]
- Clinical Trials as Topic
- Female
- Glucocorticoids/ad [Administration & Dosage]
- Glucocorticoids/bl [Blood]
- Half-Life
- Humans
- Magnetic Resonance Imaging
- Multiple Sclerosis, Relapsing-Remitting/dg [Diagnostic Imaging]
- Multiple Sclerosis, Relapsing-Remitting/pa [Pathology]
- Natalizumab/pk [Pharmacokinetics]
- Natalizumab/tu [Therapeutic Use]
- Show more
- Show less
-
Collections
-
Languages